Last reviewed · How we verify

NCT07529275: fenCo

Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent (iVascular) Implanted as Bridging Stent in FEVAR (Fenestrated Endovascular Aortic Repair) for the Treatment of Complex Abdominal Aortic Aneurysms

Recruiting now NA Last updated 14 April 2026
What this trial tests

NA trial testing iCover balloon-expandable covered peripheral stent system as bridging stent in Complex Abdominal Aortic Aneurysms in 165 participants. Currently enrolling.

Timeline
16 February 2026
Primary endpoint
30 June 2028
30 September 2028

Quick facts

Lead sponsoriVascular S.L.U.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment165
Start date16 February 2026
Primary completion30 June 2028
Estimated completion30 September 2028
Sites24 locations across France, Netherlands, Belgium, Germany, Spain

Drugs / interventions tested

Conditions studied

Sponsor

iVascular S.L.U. — full company profile →

Who can join

55 and older, any sex, with Complex Abdominal Aortic Aneurysms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

fenCo is a European multicentre, prospective study to evaluate the use of the iCover covered stents as bridging stents for reno-visceral target vessel during fEVAR for the treatment of complex abdominal aortic aneurysms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other iVascular S.L.U. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07529275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing